By Bhvita Jani
The world market for Interventional and Surgical X-ray equipment is forecast to reach almost $3.9 billion by 2024, according to a new report from Signify Research.
The world markets for interventional X-ray and surgical X-ray are estimated to have declined by 17.4% and 16.3% respectively in 2020. Growth in this market is predicted to return from 2021 onwards, as the negative impact of the pandemic is expected to subside. Recovery is forecast to be gradual rather than “V shaped”, with the steady return of elective procedures and as healthcare expenditure is restored following the diversion to COVID-related equipment.
Ad Statistics Times Displayed: 111993
Times Visited: 1576
For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
In the surgical X-ray market, flat panel detector (FPD) 2D mobile C-arms are forecast to have the fastest growth through to 2024, with a CAGR of 3.4%. In 2020, there was a shift toward low-end to mid-range FPD 2D systems as a result of stretched capital expenditure budgets. Demand for image intensifier systems is slowing down, with the key markets now the emerging regions. However, in developed markets, such as the United States, usage of imaging intensifier systems is still high in pain management clinics. 3D mobile C-arms are primarily used for imaging the joints, spinal fusion and fractures, and the market is expected to start seeing signs of recovery from 2021 onwards, following the return of elective spinal procedures to pre-pandemic levels. Regions with the highest adoption of 3D Surgical X-ray imaging include China, Western Europe and the United States.
Within the interventional X-ray market, the interventional cardiology (IC) market was more negatively impacted by COVID-19 than interventional radiology (IR) due to heavier reliance on elective procedures. An increase in the number of structural heart procedures performed, in particular, percutaneous coronary intervention (PCI), continues to be a factor maintaining clinical demand for the IC market. The IR market has experienced a continued expansion of clinical procedures being performed. An increased incidence of peripheral vascular disease is driving demand for general vascular angiography. Despite an estimated 26% drop in the hybrid operating room segment in 2020, fastest growth is predicted for this product category through to 2024.